Citadel Advisors
STIM icon

Citadel Advisors’s Neuronetics STIM Stock Holding History

Citadel Advisors’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.3K Sell
15,400
-64,100
-81% -$102K ﹤0.01% 12647
2025
Q4 		$110K Buy
79,500
+26,400
+50% +$55.2K ﹤0.01% 11554
2025
Q3 		$145K Buy
53,100
+36,700
+224% +$130K ﹤0.01% 11551
2025
Q2 		$57.2K Buy
16,400
+1,500
+10% +$5.92K ﹤0.01% 11704
2025
Q1 		$54.8K Buy
14,900
+14,700
+7,350% +$53.7K ﹤0.01% 12213
2024
Q4 		$322 Buy
+200
New +$208 ﹤0.01% 14344
2024
Q3 		– Sell
-3,800
Closed -$6.84K – 15206
2024
Q2 		$6.84K Buy
3,800
+200
+6% +$577 ﹤0.01% 13297
2024
Q1 		$17.1K Buy
3,600
+3,500
+3,500% +$12.3K ﹤0.01% 13111
2023
Q4 		$290 Sell
100
-4,000
-98% -$6.31K ﹤0.01% 14066
2023
Q3 		$5.54K Buy
4,100
+200
+5% +$350 ﹤0.01% 13385
2023
Q2 		$8.38K Buy
3,900
+2,900
+290% +$7.04K ﹤0.01% 13321
2023
Q1 		$2.91K Sell
1,000
-1,300
-57% -$6.55K ﹤0.01% 14097
2022
Q4 		$15.8K Buy
+2,300
New +$10.9K ﹤0.01% 13307

Other funds holding STIM

MAM
Madryn Asset Management New York $34.1M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors's STIM Position: Q1 2026 in Review

Citadel Advisors opened a new position in Neuronetics (STIM) in Q1 2026: 76,597 shares worth $111K. The stake represents ﹤0.01% of the portfolio and ranks #11917 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in STIM as recently as Q1 2025.

Citadel Advisors first reported a position in STIM in Q2 2018 and has held it in 24 quarters since. The position peaked at $1.03M in Q1 2021. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.

  • Citadel Advisors held 76,597 shares of Neuronetics worth $111K as of Q1 2026.
  • Neuronetics was a new Citadel Advisors position in Q1 2026.
  • Neuronetics made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11917 holding.
  • Citadel Advisors first reported a position in Neuronetics in Q2 2018 and has held it in 24 quarters since.
  • Citadel Advisors's Neuronetics position peaked at $1.03M in Q1 2021.
  • 99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.